The Global Keloid Treatment Market size in 2023 is USD 3.74 billion. The market share is projected to grow at a CAGR of 3.50% and reach USD 4.93 billion by 2031.
Global Keloid Treatment Market - Industry Overview
Keloid scars are raised, thickened areas of scar tissue that form at the site of an injury or incision, extending beyond the original wound. They occur due to an overproduction of collagen during the healing process, which causes the scar tissue to grow excessively. Factors contributing to keloid formation include genetic predisposition, excessive inflammation, and certain skin types. The global keloid treatment market is experiencing rapid growth owing to developments in treatment technologies, and an increased emphasis on cosmetic as well as dermatological care. The industry offers a wide range of therapies, including corticosteroid injections, cryotherapy, and innovative pharmaceutical techniques. Biotechnology and tailored medications are gaining headway, providing new hope for more effective therapy. Rising incidence rates of keloids, along with an increasing number of cosmetic operations and heightened consumer desire for aesthetic treatments, are fueling market growth.
Data Bridge Market Research Market Report provides details of new recent developments, market share, market trends on the basis of its segmentations and regional analysis, the impact of market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.
Global Keloid Treatment Market Size and Market Analysis
|
Global Keloid Treatment Report Metric Details
|
|
|
|
Report Metric
|
Details
|
|
|
Forecast Period
|
2024-2031
|
|
|
Base Year
|
2023
|
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
|
Measuring Unit
|
USD Billion
|
|
|
Data Pointers
|
Market value, growth rate, market segments, geographical coverage, market players, and market scenario, in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
|
Continuous innovation is considerably increasing therapeutic efficacy, with an emphasis on reducing side effects and improving patient outcomes. Advances in technology, especially more precise laser systems and specific biologic medicines, are helping to improve the management of keloid scars. The increased emphasis on cosmetic and dermatological treatment drives Global Keloid Treatment Market growth, as patients seek answers to keloids' functional and aesthetic difficulties. As a result Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Keloid Treatment Market is increasing at a CAGR of 3.50%. Our detailed analysis forecasts that the market is valued at USD 3.74 billion in 2023 and is expected to grow upto USD 4.93 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.
Global Keloid Treatment Market Dynamics
Global Keloid Treatment Market Growth Drivers
Rise in Burn Accidents
According to the World Health Organization, burns cause around 180,000 deaths each year, with the majority of cases occurring in low- and middle-income nations. For instance, the National Health Portal of India reports that approximately 6-7 million people suffer from burn injuries each year. Many individuals who experience severe burns develop keloid scars due to the overproduction of collagen during the healing process. The risk of keloid formation is particularly high in burn victims, as the extensive skin damage and subsequent healing response often lead to excessive scar tissue development. As a result, the global keloid treatment market is expected to grow in response to an increase in burn cases over the forecast period.
Growing Cosmetic and Dermatological Care
The growing focus on cosmetic procedures and dermatological care is significantly driving the demand for keloid treatments. For instance, American Society for Dermatologic Surgery (ASDS) member dermatologists performed nearly 14 million medically necessary and cosmetic procedures in 2019 – 11% more than in 2018 and a 78% increase since 2012. As more individuals seek solutions for both functional and aesthetic skin issues that lead formation of keloid scars, the demand for effective keloid treatments is increasing, highlighting the Global Keloid Treatment Market Growth potential driven by advancements in cosmetic and dermatological care.
Global Keloid Treatment Market Growth Opportunities
Emerging treatment innovations
Emerging treatment innovations for keloids present significant growth opportunities in the global market. Advances in biologic agents and gene-based therapies are leading the way, with JAK inhibitors such as ruxolitinib being investigated for their potential to reduce scar tissue formation by modulating immune responses. Concurrently, gene-editing technologies like CRISPR/Cas9 aim to target and modify genes involved in keloid development, offering new avenues for more effective management.
Advanced surgical procedure
Advanced surgical procedure such as Radiation treatment involves targeted radiation therapy to inhibit the excessive collagen production that characterizes keloid scars, effectively reducing their size and appearance. With increasing adoption and advancements in radiation technology, this method is gaining recognition for its efficacy in preventing keloid recurrence and improving patient outcomes. As awareness and utilization of radiation treatment expand for its effectiveness, it is expected to drive Global Keloid Treatment Market growth.
Global Keloid Treatment Market growth Challenges
Limited Access to Advanced Therapies
Limited access to advanced keloid treatment options, such as novel biologics and state-of-the-art laser therapies, poses a significant challenge to global market growth. In particular, low-resource settings frequently face barriers to accessing advanced therapies due to high costs, lack of infrastructure, and limited healthcare budgets. Such disparity creates a significant gap in treatment options available to patients in underserved areas, restricting their ability to benefit from the latest advancements in keloid care.
Lack of technical skills.
The exorbitant expense of advanced keloid treatments, such as sophisticated laser therapy and newer biologic medications, is a major impediment to Global Keloid Treatment Market growth. Laser therapies, such as fractional laser resurfacing, can cost thousands of dollars each session, nonetheless biologic medications, aimed at specific pathways implicated in keloid formation, are typically exorbitantly priced due to their complex development and manufacturing processes.
Global Keloid Treatment Market Restraints
Increased regulations constraining the growth of the global Keloid Treatment market
Regulatory hurdles can significantly impact the global keloid treatment market growth, with approval processes varying greatly across different regions. For instance, in countries like India and Brazil, obtaining regulatory approval for new keloid treatments is challenging. In India, the CDSCO requires extensive data and local trials, while Brazil’s ANVISA has a rigorous approval process. These regulatory differences can delay and increase costs for new keloid treatments.
Variability in Treatment Efficacy
Keloid treatment efficacy varies due to individual factors like genetics and keloid location. For instance, corticosteroid injections may be effective for some but less so for others with severe keloids. Similarly, laser therapy might work differently depending on the keloid’s location, complicating the creation of universal treatment protocols and leading to inconsistent patient outcomes. Consequently restraining the Global Keloid Treatment Market growth.
Global Keloid Treatment Market Scope and Trends
|
Global Keloid Treatment Market Segmentations Overview
|
|
|
Market
|
Sub-Segments
|
|
Product Type
|
Injectables, laser products (carbon dioxide, pulse-dyed, and others), topical products (gels, creams, silicone sheets, and others)
|
|
Treatment Type
|
Radiation Therapy (external beam radiation therapy (EBRT) and internal radiation therapy), Surgical Intervention, Steroid Injections, Others
|
|
Route of Administration
|
Oral, Parenteral
|
|
End-Users
|
Hospitals, Specialty Clinics, Homecare, Others
|
|
Distribution Channel
|
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
|
- Silicone-based creams have become popular due to their ability to hydrate and create a protective barrier that helps in softening and flattening keloids. Corticosteroid creams, on the other hand, reduce inflammation and collagen production, which can help diminish the size of keloids.
- Intensity-Modulated Radiation Therapy (IMRT) and stereotactic radiosurgery are newer techniques being explored to deliver precise radiation doses to keloid lesions while sparing surrounding healthy tissue.
- Combined surgery and radiation therapy is being explored to reduce keloid recurrence rates. Post-surgical radiation helps to prevent the keloid from reforming by targeting residual fibroblasts and minimizing collagen production.
- Advanced dressings and silicone gel sheeting are used post-operatively to reduce tension and support proper healing. Additionally, customized compression garments are recommended to manage pressure on the treated area and prevent keloid reformation.
Global Keloid Treatment Market Regional Analysis – Market Trends
|
Global Keloid Treatment Market Regional Overview
|
|
|
|
Region
|
Countries
|
|
|
Europe
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
|
|
|
APAC
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
|
|
|
North America
|
U.S., Canada, and Mexico
|
|
|
MEA
|
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East, and Africa
|
|
|
South America
|
Brazil, Argentina, and Rest of South America
|
|
Key Insights
- The North American keloid treatment market is driven by advanced healthcare infrastructure and high adoption of innovative therapies. The U.S. and Canada have robust regulatory frameworks that support the development and availability of cutting-edge treatments such as biologics and laser therapies.
- Asia-Pacific region, the keloid treatment market is experiencing rapid growth due to increasing healthcare access and rising awareness. Countries like Japan, China, and India are emerging as key markets, with a growing emphasis on both traditional and advanced treatment options.
- The keloid treatment market in Latin America is expanding as healthcare infrastructure improves and awareness of advanced treatments increases. Brazil and Mexico are prominent markets, though high costs and limited availability of cutting-edge therapies can hinder market growth.
- The Middle East and Africa face significant challenges in the keloid treatment market due to limited healthcare resources and varying levels of access to advanced treatments. Key markets in Middle East and African region include South Africa and Saudi Arabia, where efforts are underway to address these challenges and expand treatment availability.
Global Keloid Treatment Market Leading Players
- Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Sun Pharmaceutical Industries Ltd. (India)
- Merck & Co., Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Lilly (U.S.)
- Revitol (U.S.)
- Renovo Group plc (U.K.)
- AVITA Medical (U.S.)
Global Keloid Treatment Market Recent Developments
- In April, 2024 AFT Pharmaceuticals has entered into a development deal with Massey Ventures and the Gillies McIndoe Research Institute to provide a topical therapy for hypertrophic and keloid scarring.
- In January 2023, Sonoma Pharmaceuticals, Inc. launched a line of office dispense products, including Regenacyn® Plus, Reliefacyn® Plus, and Rejuvacyn® Plus, designed for skin care professionals. Regenacyn Plus, in particular, has demonstrated in clinical trials its effectiveness in reducing itching and pain associated with keloid and hypertrophic scars, and improving their appearance, texture, and color.
- In March 2023, Galderma introduced FACE by Galderma™, an innovative aesthetic visualization tool that uses augmented reality (AR) to help aesthetic professionals and patients visualize the outcomes of injectable treatments during planning.
SKU-